Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended 30 September, 2023, scheduled on Thursday, 9th November, 2023 at 03:00 P.M. IST. The Earnings Call invite is enclosed for your records. The conference/Earning Call Invitation is enclosed herewith. Kindly take the same into your records and oblige.31-10-2023